The clinical parameters of gender, smoking history, nodule type, CEA, SCC-Ag, clinical stage, tumor long axis, and tumor short axis explained the differences between EGFR mutant and wild-type patients (all p < 0.05 in training set). The gene discussed is EGFR; the disease is neoplasm.